<!doctype html>
<html>
<head>
	<meta charset="utf-8">
	<title>dasigna_nov_reasanz_24022016</title>
	<meta name="apple-mobile-web-app-capable" content="yes">
	<meta http-equiv="cache-control" content="no-cache">
	<meta http-equiv="pragma" content="no-cache">
	<meta name="viewport" content="width=device-width, initial-scale=0.5, maximum-scale=0.5, user-scalable=no" />
	 
	<script src="js/veeva-library-4.2.js"></script>
	<script src="js/jquery-1.11.2.min.js"></script>
	<script src="js/jquery.transit.min.js"></script>
	 
	<script>
        var buttonLeft = "";
        var buttonRight = "";
    </script>
    
    <script src="js/Core.js"></script>
    <script src="js/Slide.js"></script>
    
	<link href="styles/Global.css" rel="stylesheet" type="text/css">
	<link href="styles/Slide.css" rel="stylesheet" type="text/css">
	 
</head>
	<body>
		
		<div id="display">	

            <div id="bg"></div>
            <div id="links"></div>
            <div id="logo_bottom"></div>
            <!------------CONTENT------------>
            
            <div id="title"></div>
            <div id="link_over">
               <div id="link_over_top">
                <div class="link" id="link_2_3"><span>Слайд 2, 3.</span><br>1. Диагностика и лечение острой сердечной недостаточности. Кардиоваскулярная терапия и профилактика, 2006;5(6). <br>Приложение 1.<br>2. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. European Heart Journal 2012; 33: 1787–1847.</div>
                <div class="link" id="link_4"><span>Слайд 4.</span><br>KimmenadeRRJ, JanuzziJL. Clinical Chemistry 2012;58(1):127-38.</div>
                <div class="link" id="link_5_6"><span>Слайд 5, 6.</span><br>Steg P.G. et al. Circulation 2004;109:494-499.</div>
                <div class="link" id="link_7"><span>Слайд 7.</span><br>1. Kristensen S.D. et al. 2014  ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management European Heart Journal (2014) 35, 2383–2431<br>2. Mangano D.T et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery.The Study of Perioperative Ischemia Research Group.N. Engl. J. Med. 323, 1781-1788 (1990).<br>3. Healy, K. O. et al. Perioperative outcome and long-term mortality for heart failure patients undergoing intermediate- and high-risk noncardiac surgery: impact of left ventricular ejection fraction. CongestHeartFail 16, 45–49 (2010).<br>4. Hernandez A.F et al. Outcomes in heart failure patients after major noncardiac surgery.J. Am. Coll. Cardiol. 44, 1446-1453 (2004).</div>
                <div class="link" id="link_8"><span>Слайд 8.</span><br>1. Ronco, C., et al. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. (2010) Eur. Heart J. 31, 703–711.<br>2. Latchamsetty, R., et al. (2007). Prognostic value of transient and sustained increase in in-hospital creatinine on outcomes of patients admitted with acute coronary syndrome. Am. J. Cardiol. 99, 939–942.<br>3. Национальные рекомендации: Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио-нефропротекции  Российский кардиологический журнал 2014, 8 (112): 7–37.</div>
                
                
                <div class="link" id="link_9"><span>Слайд 9. </span><br>Арутюнов Г.П. и соавт. Первое открытое исследование синдрома острой декомпенсации сердечной недостаточности   и сопутствующих заболеваний в Российской Федерации. Независимый регистр ОРАКУЛ-РФ. Кардиология 2015; 5: 12-21.</div>
                <div class="link" id="link_10-14"><span>Слайд 10-14.</span><br>1. Патофизиология. П/ред. В.В. Новицкого, Е.Д. Гольдберга, О.И. Уразовой.,  ГЭОТАР-Медиа, 2009, Т.2, 640 с.<br>2. Пропедевтика внутренних болезней. Василенко В.Х., Гребенев А.Л., и др. Медицина, 2001, 592 с.<br>3. Моисеев В.С. и др., Диагностика и лечение острой сердечной недостаточности “Кардиоваскулярная терапия и профилактика” 2006; 5 (6).</div>
                <div class="link" id="link_15"><span>Слайд 15.</span><br>Арутюнов А.Г. и др., Первое открытое исследование синдрома острой декомпенсации сердечной недостаточности и сопутствующих заболеваний в Российской Федерации. Независимый регистр ОРАКУЛ-РФ. Кардиология, №5, 2015.</div>
                <div class="link" id="link_16"><span>Слайд 16.</span><br>Maggionietal. EurJHeartFail 2010;12:1076-84; <br>2. Lucas et al. Am Heart J 2000;140:840-7.</div>
                <div class="link" id="link_17"><span>Слайд 17.</span><br>1.Metra, European Journal of Heart Failure 2010; 12: 1130-1139; 2.Cotter et al. Cardiology 2010; 115: 29-36</div>
                <div class="link" id="link_18"><span>Слайд 18.</span><br>Felker et al. CircHeart Fail 2010;3:314–25; 2. Cotter et al. Cardiology 2010;115:29-36; 3. Metraetal. EurJHeartFail. 2010;12:1130-9.</div>
                <div class="link" id="link_19"><span>Слайд 19.</span><br>Диагностика и лечение острой сердечной недостаточности, Кардиоваскулярная терапия и профилактика, 2006; 5 (6),</div>
                
                
                <div class="link" id="link_20"><span>Слайд 20.</span><br>
                    <div class="column-2">
                        <p>1. Gheorghiade M. & Pang P. J Am CollCardiol 2009;53(7):557-73;<br>2. Hall. J Card Fail 2005;11(5 Suppl):S81-3;<br>3. Ichiki , Burnett. Circulation 2010;122:229–32; <br>4. Biolo A, et al. CircHeart Fail 2010;3:44-50;<br>5. Maisel et al. J Am CollCardiol 2010;55:2062–76;</p>
                        <p>6. Nikolaou et al. Eur Heart J 2013;34:742-9;<br>7. Biegus et al. Pol Arch Med Wewn 2012;122:471–9; <br>8. Ambrosy et al. Eur J Heart Fail 2012;14:302-11;<br>9. Metra et al. J Am CollCardiol 2013;61:196–206; <br>10. Damman et al. Heart Fail Rev 2012;17:241-50;</p>
                    </div>
                </div>
                <div class="link" id="link_21"><span>Слайд 21.</span><br>Metra, M., et al. (2013). Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J. Am. Coll. Cardiol. 61, 196–206.</div>
                <div class="link" id="link_22"><span>Слайд 22.</span><br>Adapted from Du S, et al. Nat Rev Cardiol 2010;7:48–58.</div>
                <div class="link" id="link_23"><span>Слайд 23.</span><br>
                    <div class="column-2">
                        <p>1.Kohsaka et al. BiolReprod 1998;59:991–9; <br>2. Hsu et al. Science 2002;295:671–4; <br>3. Novak et al. FASEB J 2006;20:2352–62; <br>4. Conrad, Shroff. CurrHypertens Rep 2011;13:409–20; <br>5. McGuane et al. Endocrinology 2011;152:2786–96; <br>6. Schneider et al. Ann RevPharmacolToxicol 2007;47:731–59; </p>
                        <p>7. Danielson,Conrad. J App Physiol 2003;95:1509–14; <br>8.Danielson et al. Am J Physiol 2000;279:R1298–304; <br>9. Dschietzig et al. CircRes 2003;92:32–40; <br>10. McGuane et al. Hypertension 2011;57:1151–60; <br>11. Dschietzig et al. J CardFailure 2009;15:182–90</p>
                    </div>
                </div>
                <div class="link" id="link_25"><span>Слайд 25.</span><br>1. Teerlinketal. Lancet 2013;381:29–39<br>2. MetraMetal. J Am CollCardiol 2013;61:196-206.</div>
                <div class="link" id="link_26_27"><span>Слайд 26, 27.</span><br>1. Teerlink et al. Lancet 2009;373:1429–39; <br>2. Teerlink et al. Lancet 2013;381:29–39.</div>
                
                <div class="link" id="link_28"><span>Слайд 28.</span><br>1. Teerlink et al. Lancet 2013;381:29–39<br>2. Metra M, et al. EuropeanHeart Journal 2013;34(40):3128-36.</div>
                <div class="link" id="link_29_30"><span>Слайд 29, 30.</span><br>G. Michael Felker et al. Effect of Serelaxin on Mode of Death in Acute Heart Failure. Results From the RELAX-AHF Study. Journal of  the American College of Cardiology, 2014; 64(15):1591-98.</div>
                <div class="link" id="link_31-34"><span>Слайд 31-34.</span><br>RELAX-AHF=RELAX in Acute Heart Failure; Teerlink et al. Lancet 2013;381:29-39.</div>
                <div class="link" id="link_35"><span>Слайд 35.</span><br>Ponikowski, P., et al., A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure. Eur Heart J 2014, 35, 431–441.</div>
                <div class="link" id="link_36"><span>Слайд 36.</span><br>Teerlink, J.R., et al. (2013). Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29–39.</div>
                <div class="link" id="link_37_39-43"><span>Слайд 37, 39-43.</span><br>Metra, M., et al. (2013). Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes. J. Am. Coll. Cardiol. 61, 196–206.</div>
                <div class="link" id="link_44_45"><span>Слайд 44, 45.</span><br>RELAX-AHF=RELAXin in Acute Heart Failure; Teerlink et al. Lancet 2013;381:29-39.</div>
                <div class="link" id="link_46"><span>Слайд 46.</span><br>Teerlink, J.R., et al. (2013). Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet 381, 29–39.</div>
                
                <div class="link" id="link_47_48"><span>Слайд 47, 48.</span><br>1. Патофизиология. П/ред. В.В. Новицкого, Е.Д. Гольдберга, О.И. Уразовой.,  ГЭОТАР-Медиа, 2009, Т.2, 640 с.<br>2. Пропедевтика внутренних болезней. Василенко В.Х., Гребенев А.Л., и др. Медицина, 2001, 592 с.<br>3. Моисеев В.С. и др., Диагностика и лечение острой сердечной недостаточности “Кардиоваскулярная терапия и профилактика” 2006; 5 (6).</div>
                <div class="link" id="link_49-70"><span>Слайд 49-70.</span><br>Инструкция по применению лекарственного препарата для медицинского применения Реасанз.</div>                
                </div>
            </div>
<!--
            <div id="link1"></div>
            <div id="link2"></div>
            <div id="link3"></div>
            <div id="link4"></div>
            <div id="link5"></div>
-->
            
            <div id="btn_up"></div>
            <div id="btn_down"></div>
            
            <!--------------NAVI------------->
            <div id="button_left"></div>
            <div id="button_right"></div>

            <!--------------MODAL------------->
            <div id="modal">
                  
            </div>	
            	
		</div>
		
		</body>
</html>
